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Background: HopU1 ADP-ribosylates GRP7, suppressing plant immunity.
Results: The HopU1 structure has two novel loops required for GRP7 recognition, and HopU1 ribosylates GRP7 at an arginine
in position 49 disrupting its function.
Conclusion: HopU1 targets a conserved arginine in GRP7, disabling its ability to bind immunity-related RNA.
Significance: The mechanistic details of how HopU1 recognizes its substrate reveal how HopU1 contributes to pathogenesis.
ThePseudomonas syringae type III effectorHopU1 is amono-
ADP-ribosyltransferase that is injected into plant cells by the
type III protein secretion system. Inside the plant cell it sup-
presses immunity by modifying RNA-binding proteins includ-
ing the glycine-rich RNA-binding protein GRP7. The crystal
structure of HopU1 at 2.7-Å resolution reveals two unique pro-
truding loops, L1 and L4, not found in other mono-ADP-ribo-
syltransferases. Site-directed mutagenesis demonstrates that
these loops are essential for substrate recognition and enzy-
matic activity. HopU1 ADP-ribosylates the conserved arginine
49 of GRP7, and this reduces the ability of GRP7 to bind RNA in
vitro. In vivo, expression of GRP7 with Arg-49 replaced with
lysine does not complement the reduced immune responses of
the Arabidopsis thaliana grp7-1 mutant demonstrating the
importance of this residue for GRP7 function. These data pro-
vide mechanistic details how HopU1 recognizes this novel type
of substrate and highlights the role of GRP7 in plant immunity.
Pseudomonas syringae is a hemibiotrophic bacterial plant
pathogen that injects a suite of type III effector proteins into
host cells (1, 2). The majority of these type III effectors suppress
the innate immune system of the plant (3, 4). Plants perceive
pathogen- or microbe-associated molecular patterns (PAMPs4/
MAMPs) through specific surface-localized transmembrane
receptors and induce a response known as PAMP-triggered
immunity (PTI). Plants can also perceive pathogen effectors intra-
cellularly using nucleotide-binding site leucine-rich repeat
immune receptors. These receptors either directly or indirectly
recognize effectors and induce a response referred to as effector-
triggered immunity (ETI) (5, 6). The downstream signaling net-
works of PTI and ETI have much in common although the ETI
responses are more prolonged and robust than those of PTI and
generally include the hypersensitive response (7), a form of pro-
grammed cell death. Common outputs of PTI and ETI include
production of reactive oxygen species (ROS), transcription of
pathogenesis-related genes, and deposition of lignin and callose in
the cell wall.
P. syringae pv. tomato DC3000 contains 35 type III effec-
tors (8). Although the majority of its type III effector inven-
tory can suppress immune responses (9), only a few targets of
P. syringae type III effectors have been identified. The
diverse nature of type III effectors is illustrative of their mul-
tiple strategies to suppress host immunity. Thus far, their
targets include immune receptor complexes (10–14), down-
stream MAPK cascades (15, 16), vesicle trafficking (17), and
RNA metabolism (18). Other P. syringae effectors have been
demonstrated to localize to the chloroplast and mitochon-
dria to exert their effects (19, 20). One type III effector,
HopU1, was identified as a mono-ADP-ribosyltransferase
(mADP-RT) (18). This was the first report of an mADP-RT
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in a plant pathogen, and they have not yet been shown to
exist in plants (21).
mADP-RTs are well described toxins of bacterial animal
pathogens (22–24). They catalyze the hydrolysis of NAD and
transfer an ADP-ribose moiety onto Arg, Cys, Asn, or diph-
thamide amino acid residues (25). Through this modification,
the activity of proteins such as heterotrimeric GTP-binding
proteins, actin, and elongation factor 2 are altered, resulting in
the modulation of a wide array of processes including protein
synthesis, actin polymerization, and electrolyte secretion (26).
mADP-RTs are also present in mammals where the majority of
them are extracellular membrane-associated mADP-RTs
(ecto-ADP-RTs) that have regulatory functions, which can be
reversed by ADP-ribose hydrolases (26). There are two broad
groups of mADP-RTs: cholera toxin (CT) and diphtheria toxin
(DT) groups. The DT group also includes poly(ADP-ribosyl-
transferases) known as poly(ADP-ribose)polymerases, which
attach more than one ADP-ribose moiety onto an amino acid
residue and are well distributed in eukaryotes including plants
(26). HopU1 shares sequence similarity to mADP-RTs in ani-
mal pathogens and eukaryotes belonging to the CT group. Sev-
eral structures of this large family of proteins have been deter-
mined (27–29).
A first hint at a potential mechanism for HopU1 virulence
activity was that it targeted specific RNA recognition motif
(RRM) RNA-binding proteins including the glycine-rich RNA-
binding protein GRP7 (18). An Arabidopsis thaliana mutant
lackingGRP7wasmore susceptible to P. syringae and produced
reduced amounts of callose in response to the flg22 PAMP indi-
cating that GRP7 was a component of the plant’s innate
immune system (18). Subsequently GRP7 was implicated in
other stress responses (30, 31) and flower development (32).
Uncovering howHopU1 disables GRP7 would provide insights
into how GRP7 functions in plant immunity.
Here, we present the structure of HopU1 at 2.7-Å resolution.
It reveals two unique protruding loops, L1 and L4. These loops
are not found in other mADP-RTs and are involved in recogni-
tion of GRP7. Through site-directed mutagenesis we identify
residues critical for GRP7 binding and enzymatic activity. In
addition, we found that HopU1 ADP-ribosylates Arg-49 of
GRP7, which is a residue in the conserved ribonucleoprotein
consensus sequence 1motif within its RRM. AGRP7 derivative
with Lys substituting for Arg at position 49 was unable to com-
plement the susceptibility and immunity phenotypes exhibited
by the Arabidopsis grp7-1 mutant, demonstrating the func-
tional importance of the residue targeted by HopU1. Impor-
tantly, we show that overexpression of GRP7 enhances the
plant immune system and resistance to P. syringae. These data
uncover the molecular basis of the interaction between the
HopU1 mADP-RT and its novel substrate GRP7; furthermore,
they highlight the role of this RNA-binding protein in plant
immunity.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Transgenic Arabidopsis Plants—Esch-
erichia coli DH5 and BL21(DE3) were used for cloning and
expression of recombinant proteins following standard proto-
cols (33) and manufacturer’s instructions. P. syringae pv.
tomato strains were grown in King’s broth at 30 °C (34). Anti-
biotics used include 100 g/ml ampicillin, 20 g/ml chloram-
phenicol, 10 g/ml gentamicin, 50 g/ml kanamycin, 100
g/ml rifampicin, and 50 g/ml spectinomycin. Arabidopsis
plants used in the study include the wild-type Columbia-0
(Lehle Seeds, Round Rock, TX), and the grp7-1 mutant (a
T-DNA insertion line SALK_039556.21.25.x). For complemen-
tation, a full-length GRP7 coding sequence derived from
NM_127738.4 fused to the HA tag was placed under control of
its native promoter resulting in construct pLN2325. A similar
construct, pLN2678, was made resulting in a GRP7 derivative
that substituted an arginine with a lysine residue in position 49.
Both of these constructs were introduced into grp7-1 by Agro-
bacterium-mediated floral dip (35).
Protein Expression, Purification, and Crystallization—The
hopU1 gene was amplified by PCR and then inserted into
pGEX-6p-1 vector (GEHealthcare). All constructs were gener-
ated using PCR-based cloning strategies, and all mutants were
generated by the QuikChange mutagenesis protocol (Strat-
agene). Protein expression, purification crystallization, and
data collection have been described elsewhere (36). Briefly,
GST-tagged HopU1 and its mutants were expressed at 15 °C in
E. coli strain Rossetta cells, whereas GRP7 and its mutants were
expressed in BL21(DE3) cells. Cells were harvested and resus-
pended in buffer containing 20 mM Tris-HCl (pH 8.0), 150 mM
NaCl, supplemented with DNase and protease inhibitors. The
soluble fraction of the cell lysate was loaded onto glutathione-
Sepharose 4B column (GE Healthcare). The protein was eluted
and further purified by ion-exchange chromatography (Source
15Q; GE Healthcare) followed by gel filtration (Superdex 200;
GE Healthcare) and concentrated to 10 mg/ml for crystalliza-
tion. The crystals of HopU1 were grown by the hanging-drop
vapor-diffusion method at 4 °C by mixing 1 l of protein solu-
tion and 1 l of reservoir solution containing 0.1 M HEPES (pH
7.3), 5% PEG10000, 8% ethylene glycol. A selenomethionine
derivative of HopU1 was expressed in M9 medium containing
60 mg liter1 selenomethionine in BL21(DE3). The derivative
crystals were obtained using similar conditions as those of
native crystals.
Data Collection and Structure Determination—All crystals
were flash-cooled in liquid nitrogen with cryoprotectant con-
taining reservoir solution and 12% glycerol. Data collection was
carried out at Beamline BL17A of Photon Factory (Japan) and
Beamline BL17U at the Shanghai Synchrotron Radiation Facil-
ity. The program HKL2000 was used for data processing.
Phases forHopU1were initially determined by the single-wave-
length anomalous dispersion, and automatic model building
was performed by using the program package PHENIX (37).
Data statistics for the SeMet single-wavelength anomalous dis-
persion dataset have been published previously (36). 16 sele-
niumatomswere foundwhen resolving the phase. After density
modification, overall the figure of merit increased from 0.51 to
0.74. More than 50% of residues in one asymmetric unit were
traced into the experimental electron densitymap.The remain-
ing residues were manually built with COOT (38). The model
was refined using native dataset to 2.7-Å resolution (supple-
mental Table S1) (36). All refinements were performedwith the
program package PHENIX (37). The final models were evalu-
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ated by PROCHECK, which showed a good stereochemistry
according to the Ramachandran plot (39). The Rwork and Rfree
for the highest resolution shell (2.80–2.71) are 21.3% and
27.1%, respectively. The structure similarity search was per-
formed with DALI Server (40). All structure figures were gen-
erated by PyMOL.
HopU1-GRP7 Binding Studies—Isothermal titration calo-
rimetry was used to obtain the binding affinity between of
HopU1 and its substrate GRP7. Purified wild-type and
HopU1 mutants (in cell) with concentration of 50 M were
titrated against purified GRP7 (in syringe) with concentra-
tion of 1 mM using a VP-ITCmicrocalorimeter (MicroCal) at
10 °C. All proteins were prepared in a buffer containing 10
mM HEPES (pH 8.0), 0.1 M NaCl. The data were fitted by
software Origin 7.0.
ADP-ribosylation Assays—To determine the mADP-RT
activity of wild type and mutants of HopU1, in vitromADP-RT
reactions were set up, and electrospray ionization-mass spec-
trometry was used to detect the molecular weight changes of
HopU1 substrate, GRP7. The RRM RNA binding domain of
GRP7 (residues 1–90) was used in these assays because it has
been shown to be a substrate of HopU1 (18). Briefly, 20 ng of
purified HopU1 recombinant proteins were incubated with 0.1
mM -NAD and 2 g purified recombinant GRP7-RRM in 5
mM HEPES (pH 7.2) buffer. Reactions were performed at 25 °C
with total volumeof 20l, and 20l of acetonitrilewas added to
stop the reaction after 1 h. Finally, the samples were subjected
to electrospray ionization-mass spectrometry to detect the
molecular mass changes.
HopU1-GRP7 Protein Complex Modeling—Based on the
DALI search result and structure comparison, the structure of
the eEF2-ExoA-NAD complex (Protein Data Bank (PDB) code
2ZIT) was used as a template for the modeling of HopU1-NAD
complex. The binding site of NAD is highly conserved in both
structures, hence the position of NAD in the HopU1-NAD
complex was inferred. Because there was no available structure
for GRP7, homology modeling of the GRP7 RRM domain was
performed by SWISS-MODEL using the RRM domain of A18
hnRNP (PDB code 1X5S) as the template, which shares 45%
sequence identity with the GRP7 RRM domain (41, 42). In the
final step, the docking experiment for HopU1-NAD-GRP7-
RRM complex was achieved on ZDOCK server with residues
Gln-53, Gln-95, and Asp-96 of HopU1 and Arg-47 and Arg-49
of GRP7 used for constraint (43).
Identification of Amino Acids ADP-ribosylated by HopU1—
To identify the amino acids within GRP7 that are ADP-ribosy-
lated by HopU1, ADP-ribosylated GRP7 was separated by two-
dimensional gel electrophoresis, and modified amino acids
were identified by mass spectrometry essentially as described
previously (18). Briefly, 3 g of purified GRP7-GST was incu-
bated with HopU1 or HopU1DD and separated on immobilized
pH gradient strips with pH range of 5 to 8 in a Protean IEF Cell
(Bio-Rad), followed by standard SDS-PAGE. All spots derived
from GRP7-GST in the presence of HopU1 or HopU1DD were
cut out and subjected to tandem mass spectrometry (MS/MS).
The stained spotswere subjected to LC/MSas described (44).
Briefly, gel pieces were digested by trypsin (V5111; Promega),
and digested peptides were extracted in 5% formic acid (v/v)/
50% acetonitrile (v/v) and separated using C18 reversed phase
LC column (75m 15 cm, BEH130, 1.7m;Waters,Milford,
MA). A Q-TOF Ultima tandem mass spectrometer coupled
with a Nanoaquity HPLC system (Waters) with electrospray
ionization was used to analyze the eluting peptides. The system
was user controlled employingMassLynx software (version 4.1;
Waters) in data-dependent acquisition mode with the follow-
ing parameters: 0.9-s survey scan (380–1900 Da) followed by
up to three 1.4-s MS/MS acquisitions (60–1900 Da). The
instrument was operated at a mass resolution of 8000. The
instrument was calibrated using the fragment ion masses of
double-protonated Glu-fibrinopeptide. The peak lists of
MS/MS data were generated using Distiller (Matrix Science,
London, UK) using charge state recognition and deisotoping
with the other default parameters for Q-TOF data. Database
searches of the acquired MS/MS spectra were performed
usingMascot (version 2.2.0; Matrix Science). A custom data-
base containing the sequence of GRP7 was used for the data
searches. Search parameters used were: no restrictions on
protein molecular weight or pI, enzymatic specificity was set
to trypsin with up to 3 missed cleavage sites, carbamido-
methylation of C was selected as a fixed modification, and
methionine oxidation along with ADP-ribosylation. Mass
accuracy settings were 0.15 Da for peptide mass and 0.12 Da
for fragment ion masses.
Inhibition of GRP7 RNABinding by HopU1—Effects of ADP-
ribosylation on the GRP7 RNA binding affinity were analyzed
by first producing ADP-ribosylated GRP7 and then testing its
RNA binding ability. Different concentrations of GRP7 were
ADP-ribosylated byHopU1 (orHopU1DD as a negative control)
in 25mMTris-HCl (pH 7.4), 10mMDTT and 5M-NAD, and
a 32P-labeled RNA probe was added to the reaction mixture.
The RNA probe used was 7-UTR_WT, which has been shown
to bind GRP7 specifically (45). Bound and free RNA probes
were separated on a native PAGE in 1 TBE and exposed to
x-ray film. Gels were also exposed to PhosphorImager screens,
and the radioactive signals were quantitated using a Storm 860
scanner and ImageQuant software (Molecular Dynamics). For
analyses, ratios of bound to free probes were plotted against
GRP7 concentrations in logarithmic scales, and the dissocia-
tion constant Kd was estimated from the x intercept of the
resulting linear regression line (45).
Analyses of Immune Responses in Arabidopsis—Measure-
ment of ROS has been described previously (46, 47). Briefly,
disks of leaf tissue 0.4 cm in diameter were harvested and
floated on water in 96-well plates overnight. The water was
replacedwith a solution containing 0.5mM chemiluminescence
probe L-012 (Wako, Japan), 10mMMOPS/KOH (pH7.4), and 1
M flg22, 1M elf18 or 100g/ml shrimp chitin (Sigma). Lumi-
nescence was measured using a Synergy H4 Hybrid Multi-
Mode Microplate Reader (Biotek). Detection of callose deposi-
tion was done as described by Guo et al. (9). Plants were
infiltrated with 1 M flg22, 1 M elf18, or 100 g/ml chitin and
incubated for 16 h. Leaf samples were treated with alcoholic
lactophenol solution to remove chlorophyll and were stained
with 0.01% (w/v) aniline blue in a solution of 150 mM K2HPO4
(pH 9.5) for 30 min. The callose deposits were visualized with a
fluorescence microscope (Zeiss Axionplan 2; Carl Zeiss,
HopU1-GRP7 Effector-Target Interaction
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Oberkochen, Germany), and the number of callose deposits
was determined using ImageJ (48).
In Planta Growth and Pathogenicity Assays—Wild-typeAra-
bidopsis Columbia-0, grp7-1, or grp7-1 transgenic plants
expressing GRP7 or a GRP7R49K derivative were grown in a
growth chamber at 24 °C with 10-h days. Bacterial growth in
plants was determined by spray-inoculating Arabidopsis leaves
with DC3000, DC3000 type III defective hrcC mutant (49), or
UNL227 (50) at a cell density of 2  108 cfu/ml with 0.02%
Silwet L-77 (Lehle Seeds). The ability of bacteria to grow in
planta was examined as described previously (51). Briefly, four
leaf disks were harvested with a 0.4-cm2 cork borer 0, 2, and 4
days after inoculation. The samplesweremacerated in 250l of
sterile water for 1 min and serially diluted. Twenty microliters
of each dilution was plated on KB medium containing the
appropriate antibiotics. The colonies recovered on plates after
48 h were enumerated.
RESULTS
HopU1 mADP-RT Structure—The structure of the HopU1
mADP-RT was determined by selenium single-wavelength
anomalous diffraction with the final model refined to 2.7-Å
resolution. The statistics of structure determination and refine-
ment are summarized in supplemental Table S1. Two HopU1
molecules are found in the asymmetric unit (data not shown).
However, mADP-RT assays on samples subjected to gel filtra-
tion chromatography indicated that HopU1 exists as a mono-
mer in solution (36). Amino acid residues 1–28 corresponding
toHopU1 type III secretion signal were not built in themodel as
they lacked electron density, possibly due to intrinsic disorder
of the N terminus as indicated by secondary structure predic-
tion (see the predict protein Web site) (52).
The structure of HopU1 adopts a typical Rossmann fold,
commonly found in proteins that bind NAD (53). The overall
dimensions of HopU1 are40 45 50 Å3, and it resembles
FIGURE 1.Structure of HopU1. A, overall structure of P. syringae pv. tomato DC3000 HopU1 in a ribbon representation. The N-terminal domain is colored
in purple, C-terminal domain in red, and protruding loops L1 and L4 are shown in orange. Secondary structural elements are labeled, and two different
views of the structure are shown. B, structure-based sequence alignment of HopU1 and three representative ADP-ribosyltransferases, rat ecto-ADP-
ribosyltransferase ART2.2 (PDB code 1GXZ), ADP-ribosyltransferase C3bot2 from C. botulinum (PDB code 1R45), and C. limosum C3 exoenzyme (PDB code
3BW8). Identical residues are highlighted with dark green background, and highly conserved residues with light green background. Secondary structural
elements are colored as in A and are shown above their corresponding sequences. Conserved motifs are indicated below their corresponding
sequences. Residues that are critical for GRP7 recognition and enzymatic activity are indicated by red triangles, residues critical for enzymatic activity but
not GRP7 recognition are indicated by blue dots, and those not critical for substrate recognition or activity are indicated by green squares.
HopU1-GRP7 Effector-Target Interaction
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a bent right hand (Fig. 1A). The N-terminal domain is analo-
gous to a thumb and palm and is made up of five -helices
(1–5), connected by four loops (L1–L4), which are packed
against each other to form a compact core structure. The two
protruding loops, L1 and L4, connect1,2 and4,5, respec-
tively, and likely stabilize each other on one side. The C-termi-
nal domain resembles the fingers and is composed of two per-
pendicular -sheets, which form an atypical -sandwich fold
surrounded by three-helices (6 to8). One of the-sheets is
formed by -strands 3 and 5, and the other is formed by
-strands 1, 2, 4, 6, and 7. A central cleft located
between the N- and C-terminal domains forms a potential
NAD binding pocket (Fig. 1A).
Structure Comparison of HopU1 with Other ADP-
ribosyltransferases—To begin to analyze the structure and
function of HopU1, we performed a Dali search (40) of the
HopU1 structure versus all known structures in the PDB.
Among 451 entries with structural similarity (Z score higher
than 2.0), the top three structures with Z score higher than 8.0
were selected for the following structural comparison. These
are the rat ecto-ADP-RT ART2.2 (PDB code 1GXZ), the Clos-
tridium botulinum mADP-RT C3bot2 (PDB code 1R45), and
the Clostridium limosum C3 exoenzyme (PDB code 3BW8).
HopU1 and these three proteins superimposed well with a root
mean square deviation of 3.69 Å for 94 C atoms (for 1GXZ),
2.12 Å for 86 C atoms (for 1R45), and 2.4 Å for 48 C atoms
(for 3BW8), respectively (supplemental Fig. S1). In general, the
C-terminal core folds of HopU1 and the three proteins com-
pared are similar, adopting a mixed /-fold with a character-
istic four -stranded core. However, there are obvious differ-
ences in the structure of theN terminus ofHopU1 and the three
mADP-RTs (supplemental Fig. S1E). Unique features of
HopU1 are the two protruding loops L1 and L4 (Fig. 1B), which
are substantially shorter in the corresponding regions of the
other mADP-RTs (supplemental Fig. S1E). These two loops
may be involved in substrate recognition, which will be dis-
cussed below.
Amino acid Residues of HopU1 Important for Substrate Rec-
ognition and mADP-RT Activity—To understand the molecu-
lar mechanism of how HopU1 recognizes and ADP-ribosylates
GRP7, we introduced alanine substitutions at specific residues
in L1, L4, and near the NAD binding pocket (Fig. 2A and
supplemental Fig. S2A). A qualitativemeasure of the binding of
HopU1 (and HopU1 derivatives) with purified GRP7 was mea-
sured by isothermal titration calorimetry. In vitro ADP-ribosy-
lation of GRP7 was detected by mass spectrometry. Wild-type
HopU1showedabindingaffinitywithaKdofabout30M(Fig.2B)
and possessed strong mADP-RT activity (Fig. 2C). HopU1
mutants M1 (HopU1H49A/Q53A) and M2 (HopU1C54A/F55A/L57A),
with substitutions in loop L1, abolished the ability of HopU1 to
bind to GRP7 and its mADP-RT activity (Fig. 2B and C), indi-
cating that the L1 loop is essential for substrate recognition.
TheM3mutant (HopU1Q95A/D96A) with substitutions in the L4
loop was unable to bind GRP7 and did not possess detectable
mADP-RT activity (Fig. 2, B and C). However, the M4 mutant
(HopU1H100A/R103A/E105A/T108A), which also contains substitu-
tions in the L4 loop, only slightly decreased the HopU1 bind-
ing affinity and possessed approximately 70% of its
FIGURE 2.Effect ofHopU1mutationsonactivity andGRP7 recognition.A, structure of HopU1 indicating the location ofHopU1mutationsM1–M4 (detailed
in bottom panels). The residues changed to Ala are highlighted and shown as stick representations. The structure was rotated90° about the horizontal axis
comparedwith the view presented on the left side of Fig. 1A. B, isothermal titration calorimetry of wild-type HopU1 andHopU1 derivativesM1–M4with GRP7,
indicating the extent that theHopU1derivatives can interactwithGRP7.C, electrospray ionization-mass spectrometry results ofmADP-RT activity forwild-type
HopU1 and HopU1 derivatives. The peak of substrates and products of each enzymatic reaction are indicated. The molecular mass of GRP7 (1–90 with 4
additional residues (Gly, Pro, His, and Met) left over after affinity tag cleavage) is 11,260 Da and GRP7 with an ADP-ribose modification is 11,800 Da. The
mutations of each HopU1 mutant are as follows: M1, HopU1H49A/Q53A; M2, HopU1C54A/F55A/L57A; M3, HopU1Q95A/D96A; and M4, HopU1H100A/R103A/E105A/T108A.
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mADP-RT activity based on integration of substrate and
product peak areas (Fig. 2, B and C). Amino acid residue
Asp-96 is near the NAD binding pocket of HopU1 and
interacts directly with Gln-229 through a hydrogen bond
(2.8 Å) likely stabilizing the ARTT loop and L4 loop. Con-
sistent with this, the HopU1 M8 mutant (HopU1Q229A) lost
its ability to interact with GRP7 and no longer possessed
mADP-RT activity (supplemental Fig. S2, B and C). How-
ever, the limited effect on substrate binding and mADP-RT
activity of the M4 mutant (HopU1H100A/R103A/E105A/T108A)
suggests that residues adjacent to Q95A/D96A in the L4 loop
do not directly interact with GRP7.
It has been shown for other mADP-RTs that the ARTT loop
is essential for NAD binding and substrate recognition (54).
Two conserved glutamate residues within the ARTT loop are
required for NAD binding and mADP-RT activity. The
mutant M9 (HopU1E233A/E235A) with substitutions in the cor-
responding amino acids Glu-233 and Glu-235 showed
decreased GRP7 binding, suggesting that the ARTT loop may
also play a role in GRP7 recognition (supplemental Fig. S2, B
and C). The PN loop of HopU1 is likely not required for inter-
action with GRP7 because mutant M7 (HopU1Q202A), which
substitutes a glutamine for an alanine in the PN loop, retained
the ability to interact with GRP7 even though it no longer pos-
sessed mADP-RT activity (supplemental Fig. S2, B and C).
Mutants M5 (HopU1R112/E113A) and M6 (HopU1R119A), con-
taining amino acid substitutions in the 5-helix, showed little
reduction in their ability to bindGRP7 (supplemental Fig. S2B),
but were required for mADP-RT activity (supplemental Fig.
S2C), suggesting that they are not essential for substrate recog-
nition but critical for enzymatic activity. Because5 and the PN
loop are important for NAD binding, mutations in these
regions may affect NAD interaction and thus decrease
NAD-dependent ADP-ribosylation. Taken together, loop L1,
theN terminus of loopL4, and theARTT loop are important for
both GRP7 interaction and mADP-RT activity (supplemental
Fig. S2D). In the HopU1 structure, these three regions are close
together and form a major binding surface for interaction with
GRP7.
Arginine 49 within GRP7 Is ADP-ribosylated by HopU1—We
showed previously that arginines 47 and 49 within the RRM
RNA binding domain of GRP7 were required for HopU1 to
ADP-ribosylate GRP7 (18). Thus far, we have been unable to
determine the structure of GRP7 bound to HopU1. However,
the structures of several RRM proteins are known (55), which
allowed themodeling of the GRP7 RRMwith the HopU1 struc-
FIGURE 3. Arginine 49 of GRP7 is ADP-ribosylated by HopU1. A, structure model of HopU1-NAD-GRP7-RRM complex. HopU1 is shown in ribbon
representation, and the N-terminal domain is colored in blue, C-terminal domain in red, and protruding loops L1 and L4 are shown in yellow. GRP7-RRM
(dark green) is shown in surface representation, and NAD (purple) is shown in stick representation. B, structure model with GRP7-RRM shown as ribbon
representation. Critical HopU1 residues for interaction with GRP7 and potential ADP-ribosylation sites Arg-47 and Arg-49 are indicated in stick repre-
sentation. C, two-dimensional PAGE gels of in vitro mADP-RT reactions containing purified HopU1-His, GRP7-GST, and 32P-labeled NAD stained with
Coomassie Blue to visualize total protein or exposed to autoradiography film to identify 32P-labeled proteins. Protein spots labeled with 32P corre-
sponding to ADP-ribosylated proteins are marked with filled arrowheads, and the unlabeled spot is marked with an open arrowhead. D, mass spectro-
metric analyses of tryptic peptides derived from the abovemADP-RT reactions using nonradioactive NAD. All spots corresponding to the indicated spots
in Bwere cut out and sent for MS/MS. One fragment shown contained a higher molecular mass than predicted. The molecular mass of the arginine (y12)
corresponds to Arg-49 of GRP7 and was equal to ADP-ribosylated arginine, indicating that this residue was ADP-ribosylated by HopU1.
HopU1-GRP7 Effector-Target Interaction
DECEMBER 16, 2011•VOLUME 286•NUMBER 50 JOURNAL OF BIOLOGICAL CHEMISTRY 43277
 
 
ture. Arg-47 and Arg-49 are predicted to be near the NAD
binding pocket of HopU1 (Fig. 3, A and B), and therefore both
represent candidate ADP-ribosylation sites. To determine
which arginine residue was ADP-ribosylated by HopU1, we
employed a proteomic approach. In vitro ADP-ribosylation
reactions containing purified GRP7 and HopU1 were resolved
by isoelectric focusing and SDS-PAGE. Purified GRP7 was
composed of at least four isoforms separated by pI value of
0.2, three of which were ADP-ribosylated (Fig. 3C). It is
important to note that the different isoforms likely represent
unmodified GRP7 and one isoform of ADP-ribosylated GRP7
exhibiting pI heterogeneity due to changes inmolecular charge.
All GRP7-related spots were analyzed using MS/MS to
sequence individual tryptic peptides. A double charged ion of
m/z 1029.92 was observed in the spectra of the gel digest. The
molecular mass of this peptide, 2057.82 Da, matches the ADP-
ribosylation of the peptide (Ser-48–Lys-60), which results in a
mass shift of 541.06 Da in the peptide mass. MS/MS of this
double charged species produced a nearly complete y series of
ions through y11 that show no shift in mass, indicating that
residues 50–60 are notmodified.WhenArg-49 was present on
the peptide the molecular mass increased by 697.16 Da, con-
sistent with the addition of an ADP-ribosylated Arg residue
(Fig. 3D). Ions supporting ADP-ribosylation of this peptide
observed in theMS/MS spectrum are protonated adenine (m/z
136), AMP (m/z 348), and ADP (m/z 428) (Fig. 3D and supple-
mental Fig. S3). Additionally, trypsin specifically cleaves at the
carboxyl side of Arg and Lys residues, and we were unable to
identify trypsin cleavage sites adjacent to Arg-49, suggesting
that ADP-ribosylation of Arg-49 likely prevented cleavage by
trypsin. Arg-49 is located in the conserved ribonucleoprotein
consensus sequence 1 (RNP-1) motif of the RRM domain, and
in other RRM proteins it has been shown to interact directly
with RNA by forming a salt bridge with the phosphate group of
bound RNAs (55). Thus, HopU1 targets an amino acid that is
likely critical for GRP7 to bind RNA.
ADP-ribosylation Reduces the Ability of GRP7 to Bind RNA—
To test directly whether ADP-ribosylatedGRP7was less able to
bind RNA, we performed gel-shift assays. Affinity-purified
recombinant GRP7-GST either treated with HopU1-His or a
catalytically inactive HopU1 derivative HopU1DD-His
(HopU1E233D/E235D) (18) was incubated with the 32P-labeled
RNA oligomer ATGRP7-UTR_WT, a known GRP7 target site
within its own mRNA (45). After separation on a native poly-
acrylamide gel, a greater amount of RNA-protein complex was
present whenGRP7-GSTwas treatedwithHopU1DD-His com-
paredwithwhen itwas treatedwithHopU1-His, indicating that
ADP-ribosylated GRP7 was less efficient at binding its target
RNA (Fig. 4A). Importantly, when a GRP7-HA derivative with
Arg-49 replaced by lysine (GRP7R49K) was used less RNA-pro-
tein complex was detected, indicating that Arg-49 is important
for RNA binding in vitro (Fig. 4A). There was no detectable
higher molecular mass RNA-protein complex when GRP7R49K
was used in the gel-shift assays. However, based on the lower
molecular mass smear in the GRP7R49K lane (Fig. 4A), this pro-
tein retained some ability to bind RNA. To determine the equi-
libriumdissociation constant (Kd) for the binding ofGRP7 to its
target RNAwe redid the assay with differing amounts of GRP7-
GST (supplemental Fig. S4). The ratio of theGRP7-boundRNA
to free RNA for each GRP7-GST concentration was plotted
against the GRP7-GST concentration in logarithmic scales to
obtain the Kd (Fig. 4B). The Kd value for ADP-ribosylated
GRP7-GST preincubated with wild-type HopU1-His, was 2.11
M, which was more than twice the Kd for the unmodified
GRP7-GST, preincubated with HopU1DD-His (0.95 M). The
Kd value of the GRP7-GST treated with wild-type HopU1-His
was similar to the previously reported Kd of GRP7R49Q mutant
(this mutant is similar to GRP7R49K except that it has a Gln
instead of Lys at position 49) (45), indicating that ADP-ribosy-
lation of Arg-49 affected GRP7 binding kinetics similar to an
Arg-49 substitution. Moreover, the Kd value of GRP7-GST
treated with HopU1DD-His was similar to the previously
reported Kd of the wild-type GRP7 (45), indicating that treat-
ment of GRP7-GST with catalytically inactive HopU1 did not
significantly affect its binding kinetics. Taken together, this
clearly demonstrates that HopU1 action can interfere with the
ability of GRP7 to bind its target RNA.
Arabidopsis grp7-1 Mutant Is Complemented by Wild-type
GRP7 but Not GRP7R49K—We previously reported that two
independent Arabidopsis grp7 mutants were compromised in
FIGURE 4. ADP-ribosylation by HopU1 reduces ability of GRP7 to bind
RNA. A, electrophoretic mobility shift assay of an RNA probe with GRP7-GST
after treatment with HopU1-His or its catalytic inactivemutant HopU1DD-His.
Standard ADP-ribosylation reactions were performed with GRP7-GST or
GRP7-GSTR49K in thepresence ofHopU1orHopU1DD, and a
32P-labeledprobe
(ATGRP7 UTRWT) was added to each reaction mix. These were run on native
polyacrylamide gels and exposed to x-ray films. B, similar assays done with
differing amounts of GRP7-GST. The protein-bound and free RNA probes
were quantified using a PhosphorImager scanner. The ratio of protein-bound
and free forms of RNAwas plotted against the concentration of GRP7 using a
logarithmic scale. The x intercept allowed estimation of Kd for both HopU1
and HopU1DD as indicated. The autoradiogram used to calculate the kDa is
shown in supplemental Fig. S4.
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callose deposition in response to the 22 amino acid epitope
(flg22) from the flagellin PAMP (18). To characterize GRP7
involvement in PTI further we tested the response of the grp7-1
mutant to other PAMPs. Callose depositionwas also reduced in
the grp7-1 mutant compared with wild-type plants when
treated with elf18, the 18-amino acid epitope from the EF-Tu
PAMP, and the chitin PAMP (Fig. 5B). Furthermore, produc-
tion of ROS was reduced in the grp7-1 mutant compared with
wild-type plants in response to all three treatments (Fig. 5A).
Both phenotypes were complemented by expressing GRP7
fused to theHA epitope from its native promoter in grp7-1 (Fig.
5, A and B). Expression of GRP7-HA was confirmed with
immunoblot analysis (supplemental Fig. S5). Notably, expres-
sion of a GRP7R49K did not complement the reduced PTI phe-
notype of the grp7-1mutant (Fig. 5, A and B). Arg-49 has been
shown to be important for the ability of GRP7 to bind RNA (45)
(Fig. 4A), and ADP-ribosylation at this site by HopU1 reduces
the ability of GRP7 to bind RNA (Fig. 4A).
To determine the susceptibility of grp7 mutant plants we
infected them with wild-type P. syringae pv. tomato DC3000, a
DC3000 hrcC mutant defective in type III secretion, and
UNL227, a DC3000 polyeffector mutant lacking about one
FIGURE 5.AnArabidopsis grp7mutant is defective in PTI responses andmore susceptible to P. syringae, and these phenotypes are complemented by
wild-typeGRP7 but not by aGRP7 derivative that is reduced in its ability to bind to RNA. A and B, ROS levels in relative light units (RLU) (A) and callose (B)
in wild-type Arabidopsis Columbia-0 (Col-0), the Columbia-0 grp7-1 mutant, the grp7-1 mutant complemented with wild-type GRP7 (grp7-1(GRP7)), and the
grp7-1mutant complemented with a GRP7 derivative containing a lysine instead of an arginine at position 49 (grp7-1(GRP7R49K)) after treatment with flg22,
elf18, or chitin. C, bacterial growth in the plants listed in A of wild-type P. syringae pv. tomato DC3000, a DC3000 polyeffector mutant lacking about one third
of its type III effector inventory (UNL227), and a DC3000mutant with a defective T3SS (hrcC).D, disease symptoms at day 4 on Arabidiopsis plants described in
A after infection with wild-type DC3000.
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third of its type III effector inventory including HopU1 (50).
DC3000 grows well in Arabidopsis because it injects about 35
type III effectors that suppress PTI. The DC3000 hrcCmutant
cannot inject type III effectors, and therefore its growth is
inhibited by PTI. UNL227 grows intermediately in Arabidopsis
compared with DC3000 and the hrcCmutant because it injects
fewer type III effectors. We reported previously that the grp7-1
mutant was more susceptible to DC3000 and the hrcCmutant
compared with wild-type Arabidopsis (18). Here, we show that
ectopic expression of GRP7-HA, but not GRP7-HAR49K, was
able to restore the levels of bacterial growth in the grp7-1
mutant to those observed in the in wild-type plants (Fig. 5, C
and D). Collectively, these data indicate that the RNA binding
ability of GRP7 is required for its role in PTI.
DISCUSSION
The crystal structure of HopU1 reveals both conserved and
unique features ofmADP-RTs. HopU1 adopts a conserved four
-stranded corewith characteristic ARTT and PN loops, which
have been demonstrated to be essential for NAD binding and
ADP-ribosylation (29). Thus, the mADP-RT family of proteins
is conserved for both structure and catalytic mechanism not
only between animal pathogens and eukaryotes, but also for
plant pathogens. However, HopU1 possesses two protruding
loops, L1 and L4, which are not found in other mADP-RTs.
Functional analyses revealed that residues within these loops
are required for substrate recognition. Tsuge et al. reported
that specific residues of loop II of the Clostridium perfringens
iota toxin mADP-RT were required for substrate interaction
(56). These residues superimpose with residues Gln-95 and
Asp-96 in the L4 loop of HopU1, suggesting that this region
may play a role in substrate recognition for other mADP-RTs
(data not shown). The ARTT and PN loops are important for
substrate recognition in the majority of mADP-RTs studied,
and this was also the case for HopU1. Thus, the HopU1 struc-
ture reveals the basis for recognition of the RNA-binding pro-
tein GRP7, a novel type of substrate.
Recently, another DC3000 type III effector, HopF2, was
shown to be an mADP-RT. HopF2 targets a MAPK kinase
MKK5 and RIN4, both signal transduction components of
innate immunity (15, 57). The structure of a HopF2 homolog,
AvrPphF/HopF1 from P. syringae pv. phaseolicola has been
determined (58).HopU1 andAvrPphF donot superimposewell
(supplemental Fig. S6), sharing limited homology in the C-ter-
minal catalytic region and no similarity elsewhere in the pro-
teins. TheHopU1 structure belongs in the CT group ofmADP-
RTs whereas AvrPphF belongs to the DT group. Thus, our data
show that P. syringae has representatives of both major groups
of mADP-RTs that clearly target different substrates involved
in plant immunity.
HopU1 ADP-ribosylated GRP7 at Arg-49, which is a residue
within the conserved RNP1 motif of the RRM. Structure-func-
tion analysis of several RRM proteins including the heteroge-
neous nuclear ribonucleoprotein hnRNPA1, the spliceosomal
protein U1A, and the Drosophila sex-determination factor
SEX-LETHALhave shown that arginines in the analogous posi-
tion contact the phosphate backbone of their respective RNA
targets via salt bridges (59–61). Indeed, mutation of Arg-49
into glutamine previously has been shown to reduce the bind-
ing affinity of GRP7 for its RNA targets about 6-fold and to
interfere with the in vivo function of GRP7 (45). We show here
that ADP-ribosylation of GRP7 Arg-49 reduces the ability of
GRP7 to bind an RNA target in vitro. This is the first example of
a type III effector that modifies an RNA-binding protein inter-
fering with its ability to interact with RNA and it suggests
HopU1 subverts the immune system of the plant by interfering
with processing of immune-related transcripts.
To investigate whether Arg-49 is crucial for plant immunity
we performed a functional analysis in the A. thaliana grp7-1
T-DNA mutant that shows reduced PAMP induced callose
deposition and ROS production and enhanced susceptibility to
DC3000. Ectopic expression of wild-type GRP7 but not of the
GRP7R49K variant complements these innate immunity and
enhanced susceptibility phenotypes. Thus, it appears that
HopU1 evolved to target an amino acid in a protein that plays a
crucial role in plant immunity. Moreover, HopU1 targets a
highly conserved amino acid in the RRM, one that could not
easily be changed by evolutionary pressure. How could this
heightened level of specificity have evolved? There are several
examples of type III effectors mimicking the activity of host
proteins (62). However, plants are not known to possess
mADP-RTs, andGRP7 is not known to be regulated bymADP-
RTs. Thus, it is unlikely this is a case of effector mimicry.
Importantly, because RRM-containing RNA-binding proteins
are well represented in prokaryotes and mADP-RTs can be
used for regulation in bacteria (63, 64), it is possible that bacte-
ria may have originally evolved these effectors to regulate bac-
terial processes and later adapted them to act inside plant cells.
GRP7 has been implicated in circadian rhythms, stress
responses, and flower transition (18, 30–32, 65). Microarray
analyses revealed that ectopic overexpression of GRP7 affects
the steady-state abundance of a suite of cellular transcripts.
Among those are circadian-regulated transcripts and tran-
scripts influenced by abiotic and biotic stress (66). Because
GRP7 interacts with translational machinery components it is
likely that GRP7 plays a role in translation.5 Thus, it appears
that GRP7 is involved in several plant processes and, therefore,
likely has many different RNA cargoes. A subset of these RNA
cargoes must play important roles in plant immunity and it is
likely that the activity of HopU1 interferes with the translation
of these RNAs thereby weakening the innate immune system of
the plant.
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Table S1. Refinement statistics of HopU1 structure
a
 
Structure refinement statistics 
Resolution range (Å) 50.0-2.70  
Rwork/Rfree (%)
b
 17.87/21.18 
R.M.S. Deviation from ideality 
  Bonds, (Å) 0.010 
  Angles, (º) 1.319 
Average B factor, (Å
2
) 27.49 
Ramachandran plot statistics 
 Most favored regions (%) 89.7 
 Allowed regions (%) 8.9 
 Generously allowed regions (%) 1.4 
a the Crystallization and preliminary crystallographic analysis has been published in Lin et al. 
(2010. Acta Crystallogr Sect F Struct Biol Cryst Commun 66: 932-934). 
bRfree = ∑Test||Fobs| –|Fcalc||/∑Test |Fobs|, where “Test” is a test set of about 5% of the total  
reflections randomly chosen and set aside prior to refinement for the complex. 
 
 
Figure S1. Structure comparison of HopU1 and selected ADP-ribosyltransferases. (A) Structure of 
the HopU1 ADP-RT is shown as ribbon representation and colored in purple blue and L1 and L4 loops 
are colored yellow (B-D) Structures of the rat Ecto-ADP-RT ART2.2 (1GXZ.PDB), the Clostridium 
botulinum C3bot2 ADP-RT (1R45.PDB), and the L Clostridium limosum C3 exoenzyme ADP-RT 
(3BW8.PDB) are shown as ribbon representation and colored in green, purple, and red, respectively.(E) 
Superimposition of the four ADP-RT structures. (F) PN loop and ARTT loop are indicated in compared 
structures. (E-F) The structures are colored as in Fig. S1A-D. 
 
Figure S2. (A) Structures of HopU1 separately indicating the location of mutations M5-M9 and then 
summarized in central square. The altered residues are highlighted and shown as stick representations. (B) 
Isothermal titration calorimetry of wild type HopU1 and HopU1 mutants M5-M9 with GRP7, which 
indicates the extent that HopU1 derivatives can interact with GRP7. (C) The electrospray ionization-mass 
spectrometry results of ADP-RT activity for wild type HopU1 and HopU1 derivatives are shown. The 
peak of substrates and products of each enzymatic reaction is indicated. The molecular mass of GRP7 (1-
90, GPHM after 3C cleavage at N terminus) is 11,260 Dalton and GRP7 with an ADP ribose modification 
is 11,800 Dalton. (D) Result summary of the ADP-RT activity and substrate binding affinity for wild type 
HopU1 and HopU1 mutants M1-M9.  
 
Figure S3. MS/MS spectrum of doubly charged ion of m/z 1029.92 in the tryptic digest of GRP7. 
The spectrum contains a nearly complete series of y-type ions. Additional ions supporting ADP 
ribosylation of this peptide observed in the MS/MS spectrum are protonated adenine (m/z 136), AMP 
(m/z 348) and ADP (m/z 428). 
 
Figure S4. Electrophoretic mobility shift assay of an RNA probe with differing amounts of GRP7-
GST after treatment with HopU1 or its catalytic inactive mutant HopU1DD. Standard ADP-
ribosylation reactions were performed with varying concentrations of GRP7-GST in the presence of 
HopU1 or HopU1DD, and a 
32
P-labeled probe (ATGRP7 UTR WT) was added to each reaction mix. These 
were run on native polyacrylamide gels, and exposed to X-ray films. 
 
Figure S5. Expression of GRP7 in different transgenic A. thaliana lines.  Immunoblot using anti-HA 
antibodies showing the expression of GRP7-HA and GRP7R49K-HA in A. thaliana Col-0 and the Col-0 
grp7-1 mutant.  
 
Figure S6. Superimposed HopU1 and AvrPphF structures. Two views (A, B) of the HopU1 structure 
(blue) superimposed with the AvrPphF structure (light green). The root mean square deviation (RMSD) 
of 2.9 angstrom for 64 Cα atoms indicating that the structures did not superimpose well. The N-termini of 
both proteins are quite different. The C-terminal catalytic domains of both proteins share a similar fold 
found in ADP-RTs.  
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